Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of Gilead Sciences (GILD) Q1 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell.

The revenue increased by 16% to $6.4 billion compared to the previous year.

The net income was $1.72 billion or $1.37 per share compared to $1.55 billion or $1.22 per share of the same quarter in the previous year.

The adjusted earnings per share were $2.08 compared to $1.68 of the previous year.

  • GIlead sciences Q2 2020 earnings

Most Popular

Everything you need to know about Broadcom’s Q2 2023 earnings report

Broadcom, Inc. (NASDAQ: AVGO) on Thursday said its second-quarter 2023 earnings and revenues increased year-over-year. The chipmaker also provided guidance for the third quarter. Earnings, excluding non-recurring items, came in

HP’s (HPQ) near-term prospects look bleak as PC slump continues

Weak consumer spending and economic uncertainties are the new challenges facing the PC market which is struggling to recover from a long-drawn slowdown. HP, Inc. (NYSE: HPQ) reported a sharp

Hormel Foods (HRL): Key takeaways from the Q2 2023 earnings report

Shares of Hormel Foods Corporation (NYSE: HRL) were up over 4% on Thursday, following the company’s announcement of its second quarter 2023 earnings results. Sales fell short of estimates while

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top